Natus Medical Announces Completion of Public Offering

Business Wire, May 29, 2008

SAN CARLOS, Calif. -- Natus Medical Incorporated (Nasdaq:BABY), a leading provider of medical devices for the newborn care, hearing, and neurology markets, today announced that it completed a public offering of 4,600,000 shares of its common stock at a price of $19.50 per share, including 600,000 shares sold as a result of the underwriters' exercise of their over-allotment option in full. Natus will receive net proceeds from the offering, including the sale of the over-allotment shares, of approximately $84,300,000 before expenses. At the completion of the offering Natus had approximately 27,566,000 shares issued and outstanding.

Cowen and Company, LLC and UBS Investment Bank acted as joint bookrunning managers for the offering and Natixis Bleichroeder Inc., Needham & Company, LLC, Raymond James & Associates, Inc. and Roth Capital Partners, LLC acted as co-managers.

The offering was made solely by means of a written prospectus supplement and accompanying prospectus pursuant to an effective shelf registration statement. This press release shall not constitute an offer to sell, or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under securities laws of any such state or jurisdiction.